{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:14:20Z","timestamp":1764587660936},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cjca.2014.03.017","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T14:46:53Z","timestamp":1395413213000},"page":"647-652","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions"],"prefix":"10.1016","volume":"30","author":[{"given":"Karen","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura N.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hude","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda R.","family":"Hemmelgarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norm R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finlay A.","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.03.017_bib1","series-title":"Mortality and Burden of Disease Attributable to Major Risks","author":"Global Health Risks","year":"2009"},{"issue":"3 suppl 2","key":"10.1016\/j.cjca.2014.03.017_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1524-6175.2003.02464.x","article-title":"The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression","volume":"5","author":"Cushman","year":"2003","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjca.2014.03.017_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/HYPERTENSIONAHA.108.119784","article-title":"Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada","volume":"53","author":"Campbell","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2014.03.017_bib4","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.03.017_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cjca.2014.03.017_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.2009.02084.x","article-title":"Better adherence to antihypertensive agents and risk reduction of chronic heart failure","volume":"266","author":"Perreault","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2014.03.017_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2125.2009.03547.x","article-title":"Adherence level of antihypertensive agents in coronary artery disease","volume":"69","author":"Perreault","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2014.03.017_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","article-title":"Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention","volume":"40","author":"Kettani","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.03.017_bib9","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.03.017_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00005650-199403000-00003","article-title":"The costs of interrupting antihypertensive drug therapy in a Medicaid population","volume":"32","author":"Mccombs","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.cjca.2014.03.017_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cjca.2014.03.017_bib12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0149-2918(97)80018-5","article-title":"Varitations in compliance among hypertensive patients by drug class: implications for health care costs","volume":"19","author":"Rizzo","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.cjca.2014.03.017_bib13","first-page":"S31","article-title":"Existing treatment strategies: does noncompliance make a difference?","volume":"16","author":"Caro","year":"1998","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.cjca.2014.03.017_bib14","first-page":"556","article-title":"Medication adherence and Medicare expenditure among beneficiaries with heart failure","volume":"18","author":"Lopert","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.cjca.2014.03.017_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCULATIONAHA.110.983874","article-title":"Meta-analysis: impact of drug class on adherence to antihypertensives","volume":"123","author":"Kronish","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.03.017_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2014.03.017_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cjca.2012.01.014","article-title":"Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension","volume":"28","author":"Gee","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.03.017_bib18","series-title":"Living and dying in Ontario: an opportunity for improved health information. Institute for Clinical Evaluative Sciences (ICES) investigative report","author":"Iron","year":"2008"},{"key":"10.1016\/j.cjca.2014.03.017_bib19","unstructured":"Wilkins R. Automated geographic coding based on the Statistics Canada postal code conversion files, including postal codes through March 2009. Ottawa, Ontario, Canada: Statistics Canada;\u00a02009."},{"key":"10.1016\/j.cjca.2014.03.017_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.03.017_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0828-282X(10)70438-4","article-title":"Administrative data have high variation in validity for recording heart failure","volume":"26","author":"Quach","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.03.017_bib22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"key":"10.1016\/j.cjca.2014.03.017_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2014.03.017_bib24","series-title":"The John Hopkins Adjusted Clinical Groups\u00ae (ACG) Case-Mix System, version 6.0 release notes","author":"The John Hopkins University Bloomberg School of Public Health HSRDC","year":"2003"},{"key":"10.1016\/j.cjca.2014.03.017_bib25","doi-asserted-by":"crossref","unstructured":"Gomes T, Juurlink D, Mamdani M. Comparative adherence to oxybutynin or tolterodine among older patients. Eur J Clinical Pharmacol 2012;68:1121.","DOI":"10.1007\/s00228-012-1225-6"},{"key":"10.1016\/j.cjca.2014.03.017_bib26","doi-asserted-by":"crossref","first-page":"b2942","DOI":"10.1136\/bmj.b2942","article-title":"Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study","volume":"339","author":"Juurlink","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.03.017_bib27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.03.017_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0828-282X(08)70175-2","article-title":"Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data","volume":"24","author":"Lachaine","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.03.017_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00228-012-1261-2","article-title":"Choice of initial antihypertensive drugs and persistence of drug use\u2014a 4-year follow-up of 78,453 incident users","volume":"68","author":"Selmer","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2014.03.017_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.18553\/jmcp.2009.15.9.728","article-title":"Comparing adherence and persistence across 6 chronic medication classes","volume":"15","author":"Yeaw","year":"2009","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.cjca.2014.03.017_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1524-6175.2007.07194.x","article-title":"Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States","volume":"9","author":"Patel","year":"2007","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.cjca.2014.03.017_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.jhh.1001873","article-title":"Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study","volume":"19","author":"Bourgault","year":"2005","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.cjca.2014.03.017_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1524-6175.2007.07307.x","article-title":"Patterns and associated health services costs of antihypertensive drug modifications","volume":"10","author":"Saleh","year":"2008","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjca.2014.03.017_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/tcrm.1.2.93.62915","article-title":"A\u00a0review of studies of adherence with antihypertensive drugs using prescription databases","volume":"1","author":"Fitz-Simon","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.cjca.2014.03.017_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2009.08.008","article-title":"Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario","volume":"123","author":"Friedman","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2014.03.017_bib36","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00228-013-1555-z","article-title":"Persistence to antihypertensive drug treatment in Swedish primary healthcare","volume":"69","author":"Qvarnstr\u00f6m","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cjca.2014.03.017_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ajh.2007.33","article-title":"Predictors of persistence with antihypertensive therapy: results from the NHANES","volume":"21","author":"Bautista","year":"2008","journal-title":"Am J Hypertens"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T22:57:07Z","timestamp":1538780227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0828282X14001639"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.03.017","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}